Search company, investor...
Neuros Medical company logo

Neuros Medical

Founded Year



Series B | Alive

Total Raised


Last Raised

$38.5M | 2 yrs ago

About Neuros Medical

Neuros Medical focuses on the development of proprietary therapies for unmet needs to patients worldwide. The company’s patented platform technology, Electrical Nerve Block, focuses on the treatment of chronic pain in a variety of applications including post-amputation pain, chronic post surgical pain, and chronic migraine.

Headquarters Location

35010 Chardon Road Suite 210

Willoughby, Ohio, 44094,

United States


Missing: Neuros Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

ESPs containing Neuros Medical

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Life Sciences / Medical Devices Tech

Bioelectronic neuromodulators alleviate symptoms and treat diseases by targeting and manipulating (with electrical currents) specific electrical circuits in the body. This approach has a broad array of applications — from spinal cord stimulation for pain relief to tibial nerve stimulation for overactive bladders to vagus nerve stimulation for seizure prevention.

Neuros Medical named as Challenger among 14 other companies, including Verily Life Sciences, Stimdia Medical, and Cala Health.

Missing: Neuros Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Neuros Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neuros Medical is included in 3 Expert Collections, including Game Changers 2018.


Game Changers 2018

70 items


Medical Devices

9,414 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

Neuros Medical Patents

Neuros Medical has filed 1 patent.

The 3 most popular patent topics include:

  • Neurophysiology
  • TAAR1 agonists
  • Neurological disorders
patents chart

Application Date

Grant Date


Related Topics




Neurophysiology, Neurological disorders, Neurotechnology, Analgesics, Acute pain


Application Date


Grant Date



Related Topics

Neurophysiology, Neurological disorders, Neurotechnology, Analgesics, Acute pain



Latest Neuros Medical News

10:00 EDT Neuros Medical Announces Completion of QUEST Pivotal Trial 90-day Primary Endpoints

Jun 6, 2022

News provided by Share this article Share this article ALISO VIEJO, Calif., June 6, 2022 /PRNewswire/ -- Neuros Medical, Inc., a medical device company developing an innovative, on-demand bioelectric nerve block therapy for patients with intractable post-amputation pain, announced today the completion of its QUEST Pivotal Trial 90-day primary endpoints. QUEST outcomes will remain blinded through the 12-month follow-up period, per protocol. QUEST is a 180-subject randomized, double blinded, active sham controlled clinical trial that is being conducted under an Investigational Device Exemption (IDE). QUEST is designed to assess the safety & effectiveness of the Company's Altius® Bioelectric Nerve Block Technology to treat intractable post-amputation pain. Post-amputation pain is a significant unmet medical need, as existing treatment options are limited, and consist primarily of opioids and gabapentinoids. The Company continues its plans for expansion of its facility and future headquarters in Aliso Viejo, CA. The 10,000 square foot operation was recently certified by the designated European Notified Body, BSI, to International Standards Organization (ISO) 13485:2016. "Expansion and ISO certification of our California headquarters will enable us to add additional personnel as we prepare to submit the Altius System Pre-Market Approval application after the QUEST study is unblinded in the Fall of 2022," said William R. Patterson, PhD, Chief Technology Officer. About Neuros Medical, Inc. Neuros Medical, a bioelectric technology company, has developed the Altius system for the treatment of chronic post-amputation pain (Phantom Limb Pain and Residual Limb Pain). Altius incorporates the Company's patented platform technology, On-Demand Bioelectric Nerve Block. Patients initiate a 30-minute Altius treatment session as needed for targeted pain relief. Neuros' technology delivers a bioelectric signal to sensory nerves in the peripheral nervous system to block the pain signal. The system consists of a nerve cuff electrode (also known as a lead) placed around a peripheral nerve and an implantable pulse generator (IPG). Chronic pain is characterized as pain lasting more than 3 months in duration. Post-amputation pain includes both phantom limb and residual limb (or "stump") pain, and impacts nearly one million Americans. There are nearly two million amputees in the U.S., with 185,000 new amputations occurring every year. Post-amputation pain represents a significant unmet medical need, as existing treatment options are limited and consist primarily of opioids and gabapentinoids. For more information, please visit . Additional information regarding the QUEST IDE study can be found at . The Altius is an investigational device that is not available for sale in the United States. For additional information regarding Neuros Medical, please contact: Amy Smith, VP Global Marketing

Neuros Medical Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Neuros Medical Rank

Neuros Medical Frequently Asked Questions (FAQ)

  • When was Neuros Medical founded?

    Neuros Medical was founded in 2008.

  • Where is Neuros Medical's headquarters?

    Neuros Medical's headquarters is located at 35010 Chardon Road, Willoughby.

  • What is Neuros Medical's latest funding round?

    Neuros Medical's latest funding round is Series B.

  • How much did Neuros Medical raise?

    Neuros Medical raised a total of $80.55M.

  • Who are the investors of Neuros Medical?

    Investors of Neuros Medical include U.S. Venture Partners, Osage University Partners, Aperture Venture Partners, Prism VentureWorks, Sectoral Asset Management and 21 more.

  • Who are Neuros Medical's competitors?

    Competitors of Neuros Medical include NeuroPace, Verily Life Sciences, Theranica, Orchestra BioMed, Stimdia Medical, Cala Health, Lungpacer Medical, Saluda Medical, Cardionomic, Rune Labs and 45 more.

Compare Neuros Medical to Competitors

Synapse Biomedical Logo
Synapse Biomedical

Synapse Biomedical (SBI) was founded to commercialize the NeuRx Diaphragm Pacing System (DPS) that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency.

eNeura Therapeutics

eNeura Therapeutics develops the use of portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for the treatment of migraines.

Cala Health

Cala Health develops wearable neuromodulation therapies to deliver individualized peripheral nerve stimulation. It was founded in 2014 and is based in San Mateo, California.

Salvia BioElectronics

Salvia develops a bioelectronic foil that is placed below the skin to stimulate proven neural targets for the treatment of chronic migraine. This patent-pending neurostimulation concept is designed for optimal safety and effectiveness and opens the market for this long-awaited headache treatment. The company was founded in 2017 and is based in Eindhoven, Netherlands.

Rune Labs Logo
Rune Labs

Rune Labs works with existing and emerging neuromodulation systems to manage complex therapies and get value out of available healthcare data.

Theranica Logo

Theranica is a medical device company that develops advanced neuromodulation devices for migraine and other idiopathic pain conditions. It provides an FDA-cleared, prescribed, smartphone-controlled, drug-free wearable device for the treatment of episodic and chronic migraine in people aged 12 and older. The firm serves clients operating in the healthcare sector. It was founded in 2016 and is based in Netanya, Israel.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.